These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23662314)

  • 1. ADR: a new global phenomenon, thanks to the ICH.
    Prescrire Int; 2013 Apr; 22(137):88. PubMed ID: 23662314
    [No Abstract]   [Full Text] [Related]  

  • 2. ICH: an exclusive club of drug regulatory agencies and drug companies imposing its rules on the rest of the world.
    Prescrire Int; 2010 Aug; 19(108):183-6. PubMed ID: 20939460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives. Internet likely to open brave new world in global pharmaceuticals trade.
    Otrompke J
    Med Health; 2000 Oct; 54(39):suppl 1-4. PubMed ID: 11184825
    [No Abstract]   [Full Text] [Related]  

  • 6. Can (and should) Africa make its own medicines?
    Kardas-Nelson M
    BMJ; 2015 Apr; 350():h2178. PubMed ID: 25920478
    [No Abstract]   [Full Text] [Related]  

  • 7. New deal from the World Trade Organisation.
    Pollock AM; Price D
    BMJ; 2003 Sep; 327(7415):571-2. PubMed ID: 12969897
    [No Abstract]   [Full Text] [Related]  

  • 8. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gatekeepers and enablers: how drug regulators respond to a challenging and changing environment by moving toward a proactive attitude.
    Ehmann F; Papaluca Amati M; Salmonson T; Posch M; Vamvakas S; Hemmings R; Eichler HG; Schneider CK
    Clin Pharmacol Ther; 2013 May; 93(5):425-32. PubMed ID: 23549149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 12. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
    Correa CM
    Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
    [No Abstract]   [Full Text] [Related]  

  • 13. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
    Hentschel CC
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
    [No Abstract]   [Full Text] [Related]  

  • 14. Data and market exclusivity for pharmaceuticals in the European Community.
    Kingham RF; Castle GH
    Food Drug Law J; 2000; 55(2):209-23. PubMed ID: 12269365
    [No Abstract]   [Full Text] [Related]  

  • 15. Japan unveils 5-year plan to boost clinical research.
    McCurry J
    Lancet; 2007 Apr; 369(9570):1333-6. PubMed ID: 17455378
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to medicines report cards.
    Mullard A
    Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
    [No Abstract]   [Full Text] [Related]  

  • 17. Globalization in the pharmaceutical industry, Part I.
    Casadio Tarabusi C; Vickery G
    Int J Health Serv; 1998; 28(1):67-105. PubMed ID: 9493754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No deal in sight on cheap drugs for poor countries.
    Fleck F
    BMJ; 2003 Mar; 326(7387):465. PubMed ID: 12609924
    [No Abstract]   [Full Text] [Related]  

  • 19. Global health challenges in the pharmaceutical world.
    Abraham J
    Health Econ Policy Law; 2009 Jan; 4(Pt 1):115-27. PubMed ID: 19099620
    [No Abstract]   [Full Text] [Related]  

  • 20. Worldwide interest in global access to drugs.
    Banta HD
    JAMA; 2001 Jun; 285(22):2844-6. PubMed ID: 11401589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.